Full Text
EE197 Cost-Effectiveness of Monoclonal Antibodies (MABs) for Rheumatoid Arthritis (RA) in the United States

Abstract

Authors

N. Jordan

Back to Volume 26, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×